IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 18 September 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00934-06v1
74/12/6730    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hajjar, A. M
Right arrow Articles by Ernst, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hajjar, A. M
Right arrow Articles by Ernst, R. K

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00934-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Lack of in vitro and in vivo recognition of Francisella subspecies LPS by Toll-like receptors

Adeline M Hajjar, Megan D Harvey, Scott A Shaffer, David R Goodlett, Anders Sjostedt, Helen Edebro, Mats Forsman, Mona Byström, Mark Pelletier, Christopher B Wilson, Samuel I Miller, Shawn J Skerrett, and Robert K Ernst*

Departments of Immunology, Medicine, Medicinal Chemistry, Microbiology, and Genome Sciences. University of Washington, Seattle, Washington. United States of America, Department of Clinical Microbiology, Clinical Bacteriology, Umeå University, Umeå, Sweden, Department of NBC-Analysis, Swedish Defence Research Agency, Umeå, Sweden

* To whom correspondence should be addressed. Email: rkernst{at}u.washington.edu.


   Abstract

Francisella tularensis is an intracellular Gram-negative bacterium that is highly infectious and potentially lethal. Several subspecies exist of varying pathogenicity. Infection by only a few organisms is sufficient to cause disease depending on the model system. Lipopolysaccharide (LPS) of Gram-negative bacteria is generally recognized by Toll-like receptor (TLR) 4/MD-2 and induces a strong pro-inflammatory response. Examination of human clinical F. tularensis isolates revealed that human virulent Type A and Type B strains produced lipid A of similar structure to the non-human model pathogen of mice, F. novicida (Fn). Fn LPS or lipid A is neither stimulatory nor an antagonist for human and murine cells through TLR4 or TLR2. It does not appear to interact with TLR4 or MD-2, as it is not an antagonist to other stimulatory LPS. Consistent with these observations, aerosolization of Fn LPS or whole bacteria induced no inflammatory response in mice. These results suggest that poor innate recognition of F. tularensis allows the bacterium to evade early recognition by the host innate immune system to promote its pathogenesis for mammals.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.